These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 28301222)
1. Qualitative 3-T Proton MR Spectroscopy for the Characterization of Musculoskeletal Neoplasms: Update on Diagnostic Performance and Indications. Gondim Teixeira PA; Ledrich M; Kauffmann F; Wamba JM; Felblinger J; Blum A; Hossu G AJR Am J Roentgenol; 2017 Jun; 208(6):1312-1319. PubMed ID: 28301222 [TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification. Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519 [TBL] [Abstract][Full Text] [Related]
3. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370 [TBL] [Abstract][Full Text] [Related]
4. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615 [TBL] [Abstract][Full Text] [Related]
5. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325 [TBL] [Abstract][Full Text] [Related]
6. Characterisation of musculoskeletal tumours by multivoxel proton MR spectroscopy. Patni RS; Boruah DK; Sanyal S; Gogoi BB; Patni M; Khandelia R; Gogoi N Skeletal Radiol; 2017 Apr; 46(4):483-495. PubMed ID: 28188338 [TBL] [Abstract][Full Text] [Related]
7. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465 [TBL] [Abstract][Full Text] [Related]
8. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors. Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357 [TBL] [Abstract][Full Text] [Related]
9. [Value of 3T magnetic resonance dynamic contrast-enhanced and diffusion-weighted imaging in differential diagnosis of musculoskeletal tumors]. Qi ZH; Li CF; Ma XX; Yang H; Jiang BD; Zhang K; Yu DX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Apr; 34(2):138-45. PubMed ID: 22776599 [TBL] [Abstract][Full Text] [Related]
10. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions. Subhawong TK; Wang X; Durand DJ; Jacobs MA; Carrino JA; Machado AJ; Fayad LM AJR Am J Roentgenol; 2012 Jan; 198(1):162-72. PubMed ID: 22194493 [TBL] [Abstract][Full Text] [Related]
11. In vivo proton spectroscopy of giant cell tumor of the bone. Sah PL; Sharma R; Kandpal H; Seith A; Rastogi S; Bandhu S; Jagannathan NR AJR Am J Roentgenol; 2008 Feb; 190(2):W133-9. PubMed ID: 18212197 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Fayad LM; Barker PB; Bluemke DA Semin Musculoskelet Radiol; 2007 Sep; 11(3):240-5. PubMed ID: 18260034 [TBL] [Abstract][Full Text] [Related]
13. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors. Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823 [TBL] [Abstract][Full Text] [Related]
14. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors. Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496 [TBL] [Abstract][Full Text] [Related]
15. Added-value of advanced magnetic resonance imaging to conventional morphologic analysis for the differentiation between benign and malignant non-fatty soft-tissue tumors. Dodin G; Salleron J; Jendoubi S; Abou Arab W; Sirveaux F; Blum A; Gondim Teixeira PA Eur Radiol; 2021 Mar; 31(3):1536-1547. PubMed ID: 32885297 [TBL] [Abstract][Full Text] [Related]
16. A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T. Fayad LM; Wang X; Salibi N; Barker PB; Jacobs MA; Machado AJ; Weber KL; Bluemke DA AJR Am J Roentgenol; 2010 Jul; 195(1):W69-75. PubMed ID: 20566784 [TBL] [Abstract][Full Text] [Related]
17. [Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing tumors of bone and soft tissue]. Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):504-10. PubMed ID: 22338133 [TBL] [Abstract][Full Text] [Related]
18. MR Spectroscopy for Differentiating Benign From Malignant Solid Adnexal Tumors. Ma FH; Qiang JW; Cai SQ; Zhao SH; Zhang GF; Rao YM AJR Am J Roentgenol; 2015 Jun; 204(6):W724-30. PubMed ID: 26001263 [TBL] [Abstract][Full Text] [Related]
19. CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology Group. Panicek DM; Gatsonis C; Rosenthal DI; Seeger LL; Huvos AG; Moore SG; Caudry DJ; Palmer WE; McNeil BJ Radiology; 1997 Jan; 202(1):237-46. PubMed ID: 8988217 [TBL] [Abstract][Full Text] [Related]
20. In vivo 1H MRS for musculoskeletal lesion characterization: which factors affect diagnostic accuracy? Wang CK; Li CW; Hsieh TJ; Lin CJ; Chien SH; Tsai KB; Chang KC; Tsai HM NMR Biomed; 2012 Feb; 25(2):359-68. PubMed ID: 21793078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]